Mebendazole & Ivermectin in Oncology
PCCA Products
•
58m
Download Handouts: https://bit.ly/4jkDKwj
We invite you to watch our FREE webinar to discover how the well-known antiparasitics, mebendazole and ivermectin, are being researched as potential options in cancer therapy.
What you’ll gain by attending:
• Expert insights into the mechanisms of action behind mebendazole and ivermectin’s anticancer potential
• Review of preclinical and clinical research on its potential use.
• Exploration of therapeutic applications in cancer treatment and ongoing research
• Discussion of regulatory, safety and marketing challenges for both mebendazole and ivermectin as adjunctive cancer therapies
Speakers
• PCCA Clinical Compounding Pharmacist Catherine Henderson, PharmD, BCSCP
• PCCA Vice President of Clinical Services Matt Martin, PharmD, BCSCP
Don’t miss the chance to expand your knowledge and gain insights that could shape future treatment protocols.
Up Next in PCCA Products
-
Choosing the Right HRT Bases for Pati...
Download Handouts: https://bit.ly/3Eo3fid
Hormone replacement therapy (HRT) is breaking new ground, and we’re here to keep you ahead of the curve. Join this free, non-CE webinar to learn how PCCA's premium bases are driving better drug delivery, improved stability and, most importantly, enhanced...
-
Sublingual Semaglutide Compounds — Do...
Download Handouts: https://bit.ly/41Jsswf
When considering the sublingual route of administration for semaglutide, it is important to understand the available science, plus clinical and legal considerations. Join us for this free, non-CE webinar to stay informed and provide enhanced care.
What ...
-
Low-dose Naltrexone: What's New
Join us to discover the latest and greatest in naltrexone compounding with PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh. He'll share updated information you need to know, plus uncover new compounding options to grow your practice.
You'll learn:
New and updated LDN dosing consider...
